was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring their HIV assets... to the new company. In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline...
ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. ViiV Healthcare is highly mission-driven in our unrelenting commit...
Territory to Include, but not limited to: Los Angeles County West Role Overview: For more than 140 years, GSK has pioneered novel research methods and technologies to help protect people from infectious diseases. Our vaccines portfolio ...
Mountain West Region: CO, UT, WY, AZ, NM, & Las Vegas ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. ViiV Healt...
We make and supply medicines and vaccines all around the globe and our teams own every production stage, from creating quality products at our manufacturing sites to designing effective supply forecasting and regulatory inspections;all pow...
We make and supply medicines and vaccines all around the globe and our teams own every production stage, from creating quality products at our manufacturing sites to designing effective supply forecasting and regulatory inspections;all pow...
The Director, Content Approval - Quality and Training is a critical position within Global Medical Information and Content Approval. The Director will support the Sr Director of Quality, Training and Operations in the development, implement...
We are seeking a visionary leader to join our Oncology Translational Medicine Integrative Sciences team as the Director of Emerging Diagnostic Technologies. This role will focus on driving innovation in diagnostic technology platforms, leve...
Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our u...
GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the he...